vancomycin has been researched along with Acinetobacter Infections in 30 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (6.67) | 18.2507 |
2000's | 5 (16.67) | 29.6817 |
2010's | 21 (70.00) | 24.3611 |
2020's | 2 (6.67) | 2.80 |
Authors | Studies |
---|---|
Broomhead, M; Eriksson, E; Grolman, J; Lipsitz, S; Mooney, D; Nuutila, K; Onderdonk, A; Yang, L | 1 |
Peters, AT; Pickens, CI; Postelnick, MJ; Qi, C; Wunderink, RG; Zembower, TR | 1 |
Cipolla, A; Falcone, M; Mastroianni, CM; Oliva, A; Venditti, M; Vullo, V | 1 |
Gemperli, R; Gomez, DS; Levin, AS; Machado, AS; Oliveira, MS; Sanches, C; Santos, SRCJ; Silva Junior, CVD | 1 |
Abdelhady, W; Bayer, AS; Estellés, A; Gonzales, R; Kauvar, LM; Leighton, A; Li, L; Ryser, S; Tenorio, E; Xiong, YQ | 1 |
De Angelis, M; Garzoli, S; Marzuillo, C; Mastroianni, CM; Oliva, A; Ragno, R; Vullo, V | 1 |
Cassisa, V; Chenouard, R; Dubée, V; Eveillard, M; Kempf, M; Mahieu, R; Sanderink, D | 1 |
Huang, WL; Yeong, EK | 1 |
Abbasi, SA; Ali, Y; Hussain, K; Jamil, B; Khan, AW; Naseem, S; Shah, AA | 1 |
Amaya-Villar, R; Artero-González, ML; Bautista-Paloma, J; Corcia-Palomo, Y; Espejo-Gutiérrez de Tena, E; Garnacho-Montero, J; Gutiérrez-Pizarraya, A | 1 |
Kamei, LK; Lopes, CK; Rigatto, MH; Rocha, JL; Tuon, FF; Zavascki, AP | 1 |
Bai, Y; Di, X; Liu, B; Liu, Y; Wang, J; Wang, R; Zhang, X | 1 |
Barberis, C; Dabos, L; Famiglietti, A; Nastro, M; Rodríguez, CH; Vay, C | 1 |
Hu, L; Li, J; Liu, Y; Pan, A; Yang, H; Ye, Y | 1 |
Beader, N; Bedenić, B; Ćačić, M; Godič-Torkar, K; Mihaljević, L; Prahin, E; Vraneš, J | 1 |
Gao, Z; Hao, S; Hou, Z; Liu, B; Tian, R | 1 |
Carretero-Ledesma, M; García-Quintanilla, M; Martín-Peña, R; McConnell, MJ; Moreno-Martínez, P; Pachón, J | 1 |
Barbara, CS; Caresta, E; Ceccarelli, G; D'Abramo, A; d'Ettorre, G; Mascellino, MT; Moretti, C; Oliva, A; Papoff, P; Venditti, M; Visca, P; Vullo, V | 1 |
Cheng, J; Hu, L; Li, J; Liu, Y; Lv, N; Yang, H; Ye, Y | 1 |
Caro-Vega, JM; García-Quintanilla, M; McConnell, MJ; Moreno-Martínez, P; Pachón, J; Pulido, MR | 1 |
Bae, S; Choi, SH; Chong, YP; Kim, HS; Kim, MC; Kim, MN; Kim, SH; Kim, YS; Lee, SO; Park, SJ; Sung, H; Woo, JH | 1 |
Hong, KH; Kim, EC; Park, JS | 1 |
Bhagan-Bruno, S; Fergus, IV; Lather, N | 1 |
Pacheco, SM; Patel, JA; Postelnick, M; Sutton, S | 1 |
Chong, Y; Ha, GY; Jeong, SH; Lee, K; Lim, HS; Park, KH; Shin, JH; Yong, D | 1 |
Koulenti, D; Rello, J | 1 |
Mangino, JE; Schafer, JJ | 1 |
Fraise, AP | 1 |
Albanèse, J; Arnaud, S; Cambon, S; Miliani, Y; Rossi, P | 1 |
Gómez Navalón, LA; López Alonso, A; Salido Valle, JA | 1 |
1 review(s) available for vancomycin and Acinetobacter Infections
Article | Year |
---|---|
Hospital-acquired pneumonia in the 21st century: a review of existing treatment options and their impact on patient care.
Topics: Acinetobacter Infections; Administration, Inhalation; Aminoglycosides; Anti-Bacterial Agents; Carbapenems; Cephalosporins; Cross Infection; Drug Administration Schedule; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Humans; Methicillin Resistance; Pneumonia, Bacterial; Pneumonia, Staphylococcal; Practice Guidelines as Topic; Pseudomonas Infections; Respiration, Artificial; Vancomycin | 2006 |
29 other study(ies) available for vancomycin and Acinetobacter Infections
Article | Year |
---|---|
Immediate Treatment of Burn Wounds with High Concentrations of Topical Antibiotics in an Alginate Hydrogel Using a Platform Wound Device.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Alginates; Animals; Anti-Bacterial Agents; Burns; Female; Gentamicins; Hydrogels; Microbial Sensitivity Tests; Minocycline; Pseudomonas aeruginosa; Pseudomonas Infections; Staphylococcal Infections; Staphylococcus aureus; Swine; Vancomycin; Wound Healing; Wound Infection | 2020 |
Decreasing incidence of
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Carbapenems; Humans; Incidence; Pneumonia, Bacterial; Quinolones; Retrospective Studies; Vancomycin | 2022 |
Clinical and in vitro efficacy of colistin plus vancomycin and rifampin against colistin-resistant Acinetobacter baumannii causing ventilator-associated pneumonia.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Aged; Anti-Bacterial Agents; Antibiotics, Antitubercular; Colistin; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Humans; Male; Microbial Sensitivity Tests; Neurosurgical Procedures; Pneumonia, Ventilator-Associated; Rifampin; Subarachnoid Hemorrhage; Vancomycin | 2017 |
Clinical Outcome and Antimicrobial Therapeutic Drug Monitoring for the Treatment of Infections in Acute Burn Patients.
Topics: Acinetobacter Infections; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Burns; Child; Child, Preschool; Cross Infection; Drug Monitoring; Female; Humans; Imipenem; Infant; Intensive Care Units; Male; Meropenem; Middle Aged; Piperacillin; Pneumonia; Prognosis; Tertiary Care Centers; Thienamycins; Urinary Tract Infections; Vancomycin; Young Adult | 2017 |
A Human Biofilm-Disrupting Monoclonal Antibody Potentiates Antibiotic Efficacy in Rodent Models of both Staphylococcus aureus and Acinetobacter baumannii Infections.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Animals; Anti-Bacterial Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Aortic Valve; Biofilms; Drug Therapy, Combination; Endocarditis; Epitopes; Female; Humans; Imipenem; Methicillin-Resistant Staphylococcus aureus; Mice; Mice, Inbred BALB C; Rats; Rats, Sprague-Dawley; Staphylococcal Infections; Vancomycin | 2017 |
In-Vitro Evaluation of Different Antimicrobial Combinations with and without Colistin Against Carbapenem-Resistant
Topics: Acinetobacter baumannii; Acinetobacter Infections; beta-Lactam Resistance; Carbapenems; Colistin; Drug Combinations; Drug Resistance, Multiple, Bacterial; Humans; Rifampin; Vancomycin | 2019 |
Colistin-glycopeptide combinations against multidrug-resistant
Topics: Acinetobacter baumannii; Acinetobacter Infections; Animals; Anti-Bacterial Agents; Colistin; Disease Models, Animal; Drug Combinations; Drug Resistance, Multiple, Bacterial; Drug Synergism; Female; Glycopeptides; Mice; Mice, Inbred C3H; Microbial Sensitivity Tests; Pneumonia; Survival Rate; Teicoplanin; Vancomycin | 2019 |
Risk Factors for Multidrug-Resistant Acinetobacter baumannii Infections in a Mass Burn Casualty Incident.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adolescent; Adult; Anti-Bacterial Agents; Burns; Drug Administration Schedule; Drug Resistance, Multiple, Bacterial; Female; Humans; Male; Mass Casualty Incidents; Models, Statistical; Retrospective Studies; Risk Factors; Taiwan; Vancomycin; Wound Infection; Young Adult | 2019 |
Susceptibility pattern of tracheal tube isolates from Intensive Care Unit of Fauji Foundation Hospital Rawalpindi.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Biofilms; Cross-Sectional Studies; Drug Resistance, Bacterial; Humans; Intensive Care Units; Intubation, Intratracheal; Klebsiella Infections; Klebsiella pneumoniae; Linezolid; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Pakistan; Pneumonia, Ventilator-Associated; Polymyxin B; Pseudomonas Infections; Staphylococcal Infections; Vancomycin | 2019 |
Clinical efficacy and safety of the combination of colistin plus vancomycin for the treatment of severe infections caused by carbapenem-resistant Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Aged; Anti-Bacterial Agents; Carbapenems; Colistin; Critical Illness; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Female; Humans; Intensive Care Units; Male; Middle Aged; Renal Insufficiency; Retrospective Studies; Treatment Outcome; Vancomycin | 2013 |
Risk factors for acute kidney injury in patients treated with polymyxin B or colistin methanesulfonate sodium.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Acute Kidney Injury; Anti-Bacterial Agents; Cohort Studies; Colistin; Female; Hospital Mortality; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Polymyxin B; Pseudomonas aeruginosa; Pseudomonas Infections; Retrospective Studies; Risk Factors; Vancomycin | 2014 |
Colistin and anti-Gram-positive bacterial agents against Acinetobacter baumannii.
Topics: Acetamides; Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Colistin; Linezolid; Microbial Sensitivity Tests; Microscopy, Electron, Transmission; Oxazolidinones; Time Factors; Vancomycin | 2014 |
First isolation of Acinetobacter johnsonii co-producing PER-2 and OXA-58 β-lactamases.
Topics: Acinetobacter; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactamases; Drug Resistance, Bacterial; Female; Humans; Microbial Sensitivity Tests; Middle Aged; Vancomycin | 2014 |
Vancomycin protects against Acinetobacter baumannii infection in a Galleria mellonella model.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Animals; Anti-Bacterial Agents; Models, Animal; Moths; Vancomycin | 2015 |
Postantibiotic effect of colistin alone and combined with vancomycin or meropenem against Acinetobacter spp. with well defined resistance mechanisms.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Colistin; Drug Resistance, Multiple, Bacterial; Drug Synergism; Drug Therapy, Combination; Meropenem; Microbial Sensitivity Tests; Thienamycins; Vancomycin | 2016 |
The characteristics of post-neurosurgical bacterial meningitis in elective neurosurgery in 2012: A single institute study.
Topics: Acinetobacter Infections; Adolescent; Adult; Aged; Anti-Bacterial Agents; Child; Child, Preschool; China; Drug Resistance, Bacterial; Escherichia coli Infections; Female; Humans; Klebsiella Infections; Male; Meningitis, Bacterial; Meropenem; Middle Aged; Neurosurgical Procedures; Polymyxins; Postoperative Complications; Pseudomonas Infections; Retrospective Studies; Seasons; Staphylococcal Infections; Sulfamethoxazole; Thienamycins; Vancomycin; Young Adult | 2015 |
Lipopolysaccharide loss produces partial colistin dependence and collateral sensitivity to azithromycin, rifampicin and vancomycin in Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Antimicrobial Cationic Peptides; Azithromycin; Bacterial Proteins; Colistin; Drug Resistance, Multiple, Bacterial; Humans; Lipid A; Lipopolysaccharides; Microbial Sensitivity Tests; Microbial Viability; Rifampin; Vancomycin | 2015 |
The role of vancomycin in addition with colistin and meropenem against colistin-sensitive multidrug resistant Acinetobacter baumannii causing severe infections in a Paediatric Intensive Care Unit.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Anti-Bacterial Agents; Carbapenems; Colistin; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Female; Humans; Infant; Intensive Care Units, Pediatric; Male; Meropenem; Microbial Sensitivity Tests; Thienamycins; Vancomycin; Young Adult | 2015 |
In vivo activity of vancomycin combined with colistin against multidrug-resistant strains of Acinetobacter baumannii in a Galleria mellonella model.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Animals; Anti-Bacterial Agents; Colistin; Disease Models, Animal; Drug Resistance, Multiple, Bacterial; Drug Synergism; Drug Therapy, Combination; Humans; Larva; Moths; Vancomycin | 2016 |
Inhibition of LpxC Increases Antibiotic Susceptibility in Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Amidohydrolases; Amikacin; Anti-Bacterial Agents; Azithromycin; Bacterial Proteins; Carbapenems; Drug Resistance, Multiple, Bacterial; Imipenem; Microbial Sensitivity Tests; Minocycline; Rifampin; Tigecycline; Vancomycin | 2016 |
In Vitro Synergistic Activity of Antimicrobial Agents in Combination against Clinical Isolates of Colistin-Resistant Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Aztreonam; Bacteremia; Ceftazidime; Colistin; Drug Combinations; Drug Resistance, Multiple, Bacterial; Drug Synergism; Humans; Meropenem; Microbial Sensitivity Tests; Pneumonia, Bacterial; Retrospective Studies; Rifampin; Teicoplanin; Thienamycins; Vancomycin | 2016 |
[Two cases of vancomycin-intermediate Staphylococcus aureus isolated from joint tissue or wound].
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Humans; Joints; Male; Meropenem; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Middle Aged; Pressure Ulcer; Staphylococcal Infections; Thienamycins; Vancomycin; Vancomycin Resistance | 2008 |
Acinetobacter endocarditis presenting as a large right atrial mass: an atypical presentation.
Topics: Acinetobacter Infections; Adult; Anti-Bacterial Agents; Catheters, Indwelling; Cefepime; Cephalosporins; Diagnosis, Differential; Endocarditis, Bacterial; Female; Heart Atria; Humans; Kidney Failure, Chronic; Ofloxacin; Ultrasonography; Vancomycin | 2010 |
Prolonged triple therapy for persistent multidrug-resistant Acinetobacter baumannii ventriculitis.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Anti-Bacterial Agents; Cerebral Ventriculitis; Colistin; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Rifampin; Tobramycin; Treatment Outcome; Vancomycin | 2011 |
Further increase of vancomycin-resistant Enterococcus faecium, amikacin- and fluoroquinolone-resistant Klebsiella pneumoniae, and imipenem-resistant Acinetobacter spp. in Korea: 2003 KONSAR surveillance.
Topics: Acinetobacter; Acinetobacter Infections; Amikacin; Anti-Bacterial Agents; Drug Resistance, Bacterial; Enterococcus faecium; Fluoroquinolones; Gammaproteobacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Korea; Microbial Sensitivity Tests; Population Surveillance; Vancomycin; Vancomycin Resistance | 2006 |
Multidrug-resistant Acinetobacter baumannii osteomyelitis from Iraq.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Drug Resistance, Multiple, Bacterial; Humans; Iraq; Male; Middle Aged; Minocycline; Osteomyelitis; Tigecycline; Vancomycin | 2008 |
Antibiotic resistance. Epidemiology of resistance in intensive therapy units (ITUs).
Topics: 4-Quinolones; Acinetobacter; Acinetobacter Infections; Anti-Bacterial Agents; Anti-Infective Agents; beta-Lactamases; Cephalosporins; Cross Infection; Drug Resistance, Microbial; Enterococcus; Enzyme Induction; Gram-Negative Bacteria; Gram-Positive Bacterial Infections; Humans; Incidence; Intensive Care Units; Methicillin Resistance; Mutation; Prevalence; Risk Factors; Staphylococcal Infections; Staphylococcus aureus; United Kingdom; Vancomycin | 1997 |
[Severe agranulocytosis induced by carbamazepine (Tegretol)].
Topics: Acinetobacter Infections; Adult; Agranulocytosis; Analgesics, Non-Narcotic; Anti-Bacterial Agents; Anti-Infective Agents; Carbamazepine; Ciprofloxacin; Humans; Male; Quadriplegia; Respiration, Artificial; Vancomycin | 1999 |
[Alpha-1-antitrypsin in early infections after hip prosthesis surgery].
Topics: Acinetobacter Infections; Adult; Aged; Aged, 80 and over; alpha 1-Antitrypsin; Anti-Bacterial Agents; Antibiotic Prophylaxis; Blood Sedimentation; C-Reactive Protein; Cefamandole; Cephalosporins; Clinical Enzyme Tests; Data Interpretation, Statistical; Female; Hip Prosthesis; Humans; Male; Middle Aged; Nephelometry and Turbidimetry; Postoperative Care; Prospective Studies; Prosthesis-Related Infections; Sensitivity and Specificity; Staphylococcal Infections; Staphylococcus epidermidis; Time Factors; Tobramycin; Vancomycin | 2000 |